References
- Popescu LM, Faussone-Pellegrini MS. Telocytes – a case of serendipity: the winding way from interstitial cells of Cajal (ICC), via interstitial Cajal-like cells (ICLC) to telocytes. J. Cell. Mol. Med.14(4), 729–740 (2010).
- Cismasiu VB, Radu E, Popescu LM. MiR-193 expression differentiates telocytes from other stromal cells. J. Cell. Mol. Med.15(5), 1071–1074 (2011).
- Gherghiceanu M, Manole CG, Popescu LM. Telocytes in endocardium: electron microscope evidence. J. Cell. Mol. Med.14(9), 2330–2334 (2010).
- Gherghiceanu M, Popescu L. Cardiomyocyte precursors and telocytes in epicardial stem cell niche. Electron microscope images. J. Cell. Mol. Med.14(4), 871–877 (2010).
- Hinescu ME, Gherghiceanu M, Suciu L et al. Telocytes in pleura: two- and three-dimensional imaging by transmission electron microscopy. Cell Tissue Res.343(2), 389–397 (2011).
- Kostin S, Popescu LM. A distinct type of cell in myocardium: interstitial Cajal-like cells (ICLCs). J. Cell. Mol. Med.13(2), 295–308 (2009).
- Carmona IC, Bartolome MJ, Escribano CJ. Identification of telocytes in the lamina propria of rat duodenum: transmission electron microscopy. J. Cell. Mol. Med.15(1), 26–30 (2011).
- Hinescu ME, Popescu LM, Gherghiceanu M et al. Interstitial Cajal-like cells in rat mesentery: an ultrastructural and immunohistochemical approach. J. Cell. Mol. Med.12(1), 260–270 (2008).
- Hinescu ME, Ardeleanu C, Gherghiceanu M et al. Interstitial Cajal-like cells in human gall bladder. J. Mol. Histol.38(4), 275–284 (2007).
- Popescu LM, Ciontea SM, Cretoiu D. Interstitial Cajal-like cells in human uterus and fallopian tube. Ann. NY Acad. Sci.1101, 139–165 (2007).
- Cretoiu SM, Cretoiu D, Suciu L et al. Interstitial Cajal-like cells of human fallopian tube express estrogen and progesterone receptors. J. Mol. Histol.40(5–6), 387–394 (2009).
- Zheng Y, Li H, Manole CG et al. Telocytes in trachea and lungs. J. Cell. Mol. Med.15(10), 2262–2268 (2011).
- Rusu MC, Jianu AM, Mirancea N et al. Tracheal telocytes. J. Cell. Mol. Med. doi:10.1111/j.1582–4934.2011.01465.x. (2011) (Epub ahead of print).
- Popescu LM, Gherghiceanu M, Suciu LC et al. Telocytes and stem cells in lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tiss. Res.345(3), 391–403 (2011).
- Popescu LM, Manole E, Serboiu CS et al. Identification of telocytes in skeletal muscle interstitium: implication for muscle regeneration. J. Cell. Mol. Med.15(6), 1379–1392 (2011)
- Gherghiceanu M, Popescu LM. Interstitial Cajal-like cells (ICLC) in human resting mammary gland stroma. Transmission electron microscope (TEM) identification. J. Cell. Mol. Med.9(4), 893–910 (2005).
- Suciu L, Popescu LM, Gherghiceanu M et al. Telocytes in human term placenta: morphology and phenotype. Cells Tissues Organs192(5), 325–339 (2010).
- Shalaby KH, Martin JG. Overview of asthma: the place of the T cell. Curr. Opin. Pharmacol.10(3), 218–225 (2010).
- Nakagome K, Nagat M. Pathogenesis of airway inflammation in bronchial asthma. Auris Nasus Larynx38(5), 555–563 (2011).
- Saleh AM, Johnson JR, Hamid Q. Remodeling in asthma. J. Allergy Clin. Immunol.128(3), 451–462 (2011).
- Jeffrey EG, Michael A, Matthay. Mesechema stem cells and acute lung injury. Crit. Care Clin.27(3), 719–733 (2011).
- Demedts IK, Demoor T, Bracke KR et al. Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema. Respir. Res.30(7), 53 (2006).
- Hogg JC, Chu F, Utokaparch S et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N. Engl. J. Med.350(26), 2645–2653 (2004).
- Tetley TD. Inflammatory cells and chronic obstructive pulmonary disease. Curr. Drug Targets Inflamm. Allergy4(6), 607–618 (2005).
- Esmaeil M, Gert F, Frank R. Mast cells and COPD. Pulm. Pharmacol. Ther.24(4), 367–372 (2011).
- Zhao M, Amir MK, Rice WR et al. Type II pneumocyte-CD8+ T-cell interactions: relationship between target cell cytotoxicity and activation. Am. J. Respir. Cell Mol. Biol.25(3), 362–369 (2001).
- Zhao C, Fang X, Wang D et al. Involvement of type II pneumocytes in the pathogenesis of chronic obstructive pulmonary disease. Respir. Med.104(10), 1391–1395 (2010).
- Chen H, Song Z, Qian M et al. Selection of disease-specific biomarkers by integrating inflammatory mediators with clinical informatics in AECOPD patients: a preliminary study. J. Cell. Mol. Med. doi:10.1111/j.1582-4934.2011.01416.x (2011) (Epub ahead of print).
- Wang X. Role of clinical bioinformatics in the development network-based biomarkers. J. Clin. Bioinforma.1(1), 28 (2011).
- Laura A, Javier D, María B et al. Therapeutic effect of a peptide inhibitor of TGF-β on pulmonary fibrosis. Cytokine53(3), 327–333 (2011).
- Qi B, Zhao Y, Wei X et al. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis. Eur. J. Pharmacol.642(3), 134–139 (2010)
- Annika A, Carolina G, Kristian N et al. Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int. J. Biochem. Cell Biol.40(10), 2129–2140 (2008).
- Jemal A, Siegel R, Ward E et al. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
- Jonml A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J. Clin.58(2), 71–96 (2008).
- Jan PM, Dean AF, Dirk KM. Small-cell lung cancer. Lancet378(9804), 1741–1755 (2011).
- Wang X, Berezin I, Mikkelsen HB et al. Pathology of interstitial cells of Cajal in relation to inflammation revealed by ultrastructure but not immunohistochemistry. Am. J. Pathol.160(4), 1529–1540 (2002).
- Popescu LM, Sanda M, Ciontea et al. The connective connection: interstitial cells of Cajal (ICC) and ICC-like cells establish synapses with immunoreactive cells. J. Cell. Mol. Med.9(3), 714–730 (2005).
- Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J.23(6), 932–946 (2004).
- Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet364(9434), 613–620 (2004).
- Fang X, Wang X, Bai C. COPD in China: the burden and importance of proper management. Chest139(4), 920–929 (2011).
- De Lauretis A, Veeraraghavan S, Renzoni E. Review series: aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron. Respir. Dis.8(1), 53–82 (2011).
- Zheng Y, Manole CG, Bai C et al. Telocyte morphologies and potential roles in diseases. J. Cell Physiol. doi:10.1002/jcp.23022 (2011) (Epub ahead of print).
- Bhattacharya S, Tyagi S, Srisuma S et al. Peripheral blood gene expression profiles in COPD subjects. J. Clin. Bioinforma.1(1), 12 (2011).
- Lee IH, Lushington GH, Visvanathan M. A filter-based feature selection approach for identifying potential biomarkers for lung cancer. J. Clin. Bioinforma.1(1), 11 (2011).
- Baumgartner C, Osl M, Netzer M et al. Bioinformatic-driven search for metabolic biomarkers in disease. J. Clin. Bioinforma.1(1), 2 (2011).
- Wang X, Liotta L. Clinical bioinformatics: a new emerging science. J. Clin. Bioinforma.1(1), 1 (2011).
- Manole CG., Cismasiu V, Mihaela G et al. Experimental acute myocardial infarction: telocytes involvement in neo-angiogenesis. J. Cell. Mol. Med.15(11), 2284–2296 (2011).
- Zhou J, Zhang Y, Wen X et al. Telocytes accompanying cardiomyocyte in primary culture: two- and three-dimensional culture environment. J. Cell. Mol. Med.14(11), 2641–2645 (2010).